RYTM · Categories · Form 4
RYTM - SEC Form 4 insider transactions
Rhythm Pharmaceuticals Inc. (RYTM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for RYTM
- Chief Financial Officer Smith Hunter C exercised 3,000 shares at a strike of $17.87, increasing direct ownership by 3% to 119,611 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Corporate Controller & CAO German Christopher Paul exercised 4,442 shares at a strike of $42.17 and sold $428,131 worth of shares (4,643 units at $92.21), closing all direct ownership in the company (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by Mazabraud Yann4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by Popovits Kimberly J4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Director Mathers Edward T acquired 4,199 shares (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Corporate Controller & CAO German Christopher Paul sold $502,790 worth of shares (5,614 units at $89.56) and exercised 1,500 shares at a strike of $17.97, decreasing direct ownership by 96% to 160 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by EVP, Head of International Mazabraud Yann4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Director Mathers Edward T acquired 4,198 shares (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Corporate Controller & CAO German Christopher Paul covered exercise/tax liability with 342 shares and converted options into 1,162 shares, increasing direct ownership by 24% to 4,253 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Financial Officer Smith Hunter C exercised 6,099 shares at a strike of $6.80, increasing direct ownership by 6% to 116,611 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Financial Officer Smith Hunter C sold $805,814 worth of shares (7,954 units at $101.31), decreasing direct ownership by 7% to 110,512 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- EVP, Head of International Mazabraud Yann converted options into 10,000 shares, increasing direct ownership by 23% to 53,155 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by Chief Technical Officer Shulman Joseph4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by President and CEO Meeker David P4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by EVP, Head of International Mazabraud Yann4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by EVP, Head of North America Lee Jennifer Kayden4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by Corporate Controller & CAO German Christopher Paul4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Garfield Alastair4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by Chief Human Resources Officer Cramer Pamela J.4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Financial Officer Smith Hunter C sold $708,576 worth of shares (7,071 units at $100.21), decreasing direct ownership by 6% to 118,466 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Financial Officer Smith Hunter C sold $702,744 worth of shares (6,628 units at $106.03), decreasing direct ownership by 5% to 125,537 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- EVP, Head of International Mazabraud Yann converted options into 5,500 shares, increasing direct ownership by 15% to 43,155 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Financial Officer Smith Hunter C converted options into 26,000 shares and covered exercise/tax liability with 10,750 shares, increasing direct ownership by 13% to 132,165 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Technical Officer Shulman Joseph converted options into 16,968 shares and covered exercise/tax liability with 6,507 shares, increasing direct ownership by 123% to 18,970 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- President and CEO Meeker David P covered exercise/tax liability with 31,522 shares and converted options into 68,713 shares, increasing direct ownership by 18% to 239,016 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- EVP, Head of North America Lee Jennifer Kayden converted options into 22,612 shares and covered exercise/tax liability with 9,237 shares, increasing direct ownership by 228% to 19,233 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Corporate Controller & CAO German Christopher Paul covered exercise/tax liability with 1,138 shares and converted options into 3,613 shares, increasing direct ownership by 258% to 3,433 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Scientific Officer Garfield Alastair covered exercise/tax liability with 2,026 shares and converted options into 6,663 shares, increasing direct ownership by 148% to 7,763 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Human Resources Officer Cramer Pamela J. converted options into 13,293 shares and covered exercise/tax liability with 4,731 shares, increasing direct ownership by 41% to 29,376 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Human Resources Officer Cramer Pamela J. exercised 3,350 shares at a strike of $27.35 and sold $371,850 worth of shares (3,350 units at $111.00) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Human Resources Officer Cramer Pamela J. exercised 3,350 shares at a strike of $27.35 and sold $351,750 worth of shares (3,350 units at $105.00) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Human Resources Officer Cramer Pamela J. exercised 22,866 shares at a strike of $11.51 and sold $2,263,826 worth of shares (22,866 units at $99.00) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Technical Officer Shulman Joseph exercised 9,748 shares at a strike of $30.66 and sold $1,123,398 worth of shares (9,748 units at $115.24) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Technical Officer Shulman Joseph exercised 2,815 shares at a strike of $28.20 and sold $323,750 worth of shares (2,815 units at $115.01) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Technical Officer Shulman Joseph exercised 14,437 shares at a strike of $30.18 and sold $1,617,337 worth of shares (14,437 units at $112.03) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Technical Officer Shulman Joseph exercised 16,781 shares at a strike of $30.25 and sold $1,767,006 worth of shares (16,781 units at $105.30) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Technical Officer Shulman Joseph exercised 4,188 shares at a strike of $27.35 and sold $419,091 worth of shares (4,188 units at $100.07) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Financial Officer Smith Hunter C exercised 28,088 shares at a strike of $6.88 and sold $2,704,624 worth of shares (28,088 units at $96.29) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Corporate Controller & CAO German Christopher Paul exercised 1,500 shares at a strike of $28.39 and sold $142,500 worth of shares (1,500 units at $95.00) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Technical Officer Shulman Joseph exercised 3,984 shares at a strike of $6.80 and sold $358,891 worth of shares (3,984 units at $90.08) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Human Resources Officer Cramer Pamela J. converted options into 3,125 shares and sold $130,614 worth of shares (1,520 units at $85.93), increasing direct ownership by 8% to 20,814 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Financial Officer Smith Hunter C exercised 42,120 shares at a strike of $6.88 and sold $3,389,756 worth of shares (42,120 units at $80.48) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Technical Officer Shulman Joseph exercised 7,969 shares at a strike of $6.80 and sold $619,851 worth of shares (7,969 units at $77.78) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Corporate Controller & CAO German Christopher Paul exercised 2,850 shares at a strike of $27.29 and sold $308,217 worth of shares (3,817 units at $80.75), decreasing direct ownership by 51% to 922 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Human Resources Officer Cramer Pamela J. exercised 15,572 shares at a strike of $13.43 and sold $1,201,062 worth of shares (15,572 units at $77.13) (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Financial Officer Smith Hunter C exercised 6,986 shares at a strike of $6.88, increasing direct ownership by 6% to 116,915 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Chief Scientific Officer Garfield Alastair sold $85,483 worth of shares (1,319 units at $64.81) and converted options into 4,445 shares (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by Director Bedrosian Camille L4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by Director Good Jennifer L4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by Director Mathers Edward T4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by Director Jean Christophe4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by Director Arbuckle Stuart A4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by Director Tetrault Lynn A.4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- SEC Form 4 filed by Director Mcgirr David W J4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Director Mathers Edward T converted options into 4,000 shares, increasing direct ownership by 133% to 7,000 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Director Jean Christophe converted options into 4,000 shares, increasing direct ownership by 133% to 7,000 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Director Good Jennifer L converted options into 4,000 shares, increasing direct ownership by 133% to 7,000 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Director Bedrosian Camille L converted options into 4,000 shares, increasing direct ownership by 133% to 7,000 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Director Arbuckle Stuart A converted options into 4,000 shares, increasing direct ownership by 133% to 7,000 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)
- Director Mcgirr David W J converted options into 4,000 shares, increasing direct ownership by 133% to 7,000 units (SEC Form 4)4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)